Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122347) titled '?Clinical Application Research of 68Ga-Pentixafor PET/CT in Multiple Myeloma and Indolent Lymphoma' on April 13.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: chongqing university cancer hospital
Condition:
Multiple myeloma and indolent lymphoma
Intervention:
Gold Standard:Histopathology is the gold standard for disease diagnosis, while other conventional imaging modalities serve as reference standards for diagnosis and staging.
Index test:Number of lesions detected by 68Ga-Pentixafor PET/CT
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment:...